Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  KSP inhibitor ARRY-520
Find trials that include:  Any drugs shown
Results 1-3 of 3 for your search:
Start Over
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and 120
Trial IDs: ARRAY-520-216, NCI-2013-02352, ARRY 520-216, NCT01989325
A Phase 2 Trial of Filanesib in Relapsed/Refractory Multiple Myeloma (AfFIRM)
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: ARRAY-520-215, NCI-2014-01550, 2014-001051-23, NCT02092922
KSP Inhibitor ARRY-520 and Carfilzomib in Treating Patients with Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 2011-0144, NCI-2011-01120, NCT01372540
Start Over